
Gene amplification, zzso and zzso of growth factors, or the receptors themselves, causes increased signaling through zzso zzso which has been implicated in many human zzso and is associated with poor zzso zzso growth has been shown to be decreased by interrupting this process of extensive growth zzso signaling by directly targeting either the surface zzso or the zzso and thereby preventing cell survival and promoting zzso zzso zzso have long been zzso as a potential new class of zzso targeting cancer and other zzso zzso therapy initially entered clinical practice when zzso became the first clinically approved drug against an zzso product as a well-established blocking zzso for tumors with zzso of zzso growth factor signaling zzso In the first part of this review we explain basic terms related to the development of zzso drugs, give a brief historic perspective of the field, and also touch on topics such as the zzso of zzso or creation of hybrid zzso The second part of the review gives an overview of the clinical usage of zzso zzso and zzso zzso with zzso agents or zzso Further within this section, zzso zzso or signaling zzso therapies are discussed in zzso Among other zzso therapeutic products, we zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso zzso and many zzso The end of the review zzso upon potential problems associated with cancer zzso 

